Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 176 to 200 of 2529

TitleReference numberPublishedLast updated
Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 yearsNG247
Bimekizumab for treating moderate to severe hidradenitis suppurativa (terminated appraisal)TA1028
Andexanet alfa for reversing anticoagulation in people with intracranial haemorrhage (terminated appraisal)TA1029
Durvalumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancerTA1030
Andexanet alfa for reversing anticoagulation from apixaban or rivaroxabanTA697
Artificial intelligence (AI) technologies to help detect fractures on X-rays in urgent care: early value assessmentHTG739
Digitally enabled therapies for adults with depression: early value assessmentHTG675
Tebentafusp for treating advanced uveal melanomaTA1027
Electrically stimulated intravesical therapy for interstitial cystitis or overactive bladder in adultsHTG738
Transperineal laser ablation for treating lower urinary tract symptoms of benign prostatic hyperplasiaHTG737
Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndromeHTG735
Ublituximab for treating relapsing multiple sclerosisTA1025
MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson'sHTG733
MRI-guided focused ultrasound subthalamotomy for treating Parkinson'sHTG734
Direct skeletal fixation of limb prostheses using an intraosseous transcutaneous implantHTG732
Urinary tract infection (recurrent): antimicrobial prescribingNG112
Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatmentsTA1023
Toripalimab with chemotherapy for untreated advanced oesophageal squamous cell cancer (terminated appraisal)TA1024
Crizotinib for treating ROS1-positive advanced non-small-cell lung cancerTA1021
Bevacizumab gamma for treating wet age-related macular degenerationTA1022
Meningitis (bacterial) and meningococcal diseaseQS19
Asthma pathway (BTS, NICE, SIGN)NG244
Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)NG245
Eplontersen for treating hereditary transthyretin-related amyloidosisTA1020
Pembrolizumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancerTA1017

Results per page

  1. 10
  2. 25
  3. 50
  4. All